New therapies in development for autoimmune diseases: their rationale for combination treatment.
Strand, V
New therapies in development for autoimmune diseases: their rationale for combination treatment. [electronic resource] - Springer seminars in immunopathology 2001 - 43-61 p. digital
Publication Type: Journal Article; Review
0344-4325
10.1007/s002810100071 doi
Adjuvants, Immunologic--therapeutic use
Animals
Antibodies, Blocking--therapeutic use
Arthritis, Rheumatoid--immunology
Autoimmune Diseases--immunology
B-Lymphocytes--immunology
Combined Modality Therapy
Cytokines--antagonists & inhibitors
Drug Therapy, Combination
Histocompatibility Antigens Class II--immunology
Humans
Lupus Erythematosus, Systemic--immunology
Receptors, Antigen, T-Cell--immunology
T-Lymphocytes--immunology
Treatment Outcome
New therapies in development for autoimmune diseases: their rationale for combination treatment. [electronic resource] - Springer seminars in immunopathology 2001 - 43-61 p. digital
Publication Type: Journal Article; Review
0344-4325
10.1007/s002810100071 doi
Adjuvants, Immunologic--therapeutic use
Animals
Antibodies, Blocking--therapeutic use
Arthritis, Rheumatoid--immunology
Autoimmune Diseases--immunology
B-Lymphocytes--immunology
Combined Modality Therapy
Cytokines--antagonists & inhibitors
Drug Therapy, Combination
Histocompatibility Antigens Class II--immunology
Humans
Lupus Erythematosus, Systemic--immunology
Receptors, Antigen, T-Cell--immunology
T-Lymphocytes--immunology
Treatment Outcome